Form 4: VolitionRx Executive Gael Forterre Receives Stock Award in Lieu of Cash Compensation

Gael Forterre, Chief Commercial Officer of VolitionRx, received 8,944 restricted stock units (RSUs) on June 1, 2024, in lieu of cash compensation.

Summary

• Gael Forterre, the Chief Commercial Officer of VolitionRx Ltd, received 8,944 restricted stock units (RSUs) on June 1, 2024.
• These RSUs were awarded under the Issuer's 2015 Stock Incentive Plan as a substitute for cash compensation.
• The RSUs vest in installments on June 1, 2024 (2,982 units), July 1, 2024 (2,981 units), and August 1, 2024 (2,981 units), with further time-based vesting on May 1, 2025, subject to continued service.
• Upon vesting, Forterre will receive common stock equal to the number of vested RSUs.
• Forterre also indirectly owns 5,000 shares through his spouse and 32,500 shares through Armori Capital Management, LLC, where he is the managing director and sole shareholder.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of executive compensation. The use of RSUs instead of cash could be seen as slightly positive for the company's financial position.

Positives

• The award of RSUs to a key executive aligns their interests with those of the shareholders.
• Using RSUs instead of cash may preserve the company's cash reserves.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Stock-based compensation is a common practice in the biotechnology industry to attract and retain talent, especially in companies that may be cash-strapped.

Comparison to Industry Standards

• Many biotech companies use stock options and RSUs as part of their compensation packages.
• The vesting schedule of the RSUs is fairly standard, with installments over a period of months and a final vesting date further out.
• Comparing the size of the RSU award to similar companies would require analyzing their executive compensation packages.

Stakeholder Impact

• Shareholders may view the RSU grant as aligning management's interests with theirs.
• Employees may see the stock award as a positive sign of the company's commitment to its employees.

Key Dates